Anti-MALRD1 antibodies are used in the immunodetection of the protein MAM and LDL receptor class A domain containing 1. In humans, the canonical protein has a reported length of 2156 amino acid residues and a mass of 241 kDa. Its subcellular localization is in the cytoplasmic vesicles. It is reported to be highly expressed in the small intestine. MALRD1 is known to be involved with cholesterol metabolism and homeostasis. Post-translational modifications have been described, including glycosylation. Synonyms for this target antigen include MAM and LDL-receptor class A domain-containing protein C10orf112, novel MAM domain containing protein, and MAM and LDL-receptor class A domain-containing protein 1. MALRD1 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. These malrd1 antibodies are widely used in Immunocytochemistry experiments, among other applications.